Literature DB >> 19043457

Cutaneous lymphocyte antigen-positive T cells may predict the development of acute GVHD: alterations and differences of CLA+ T- and NK-cell fractions.

J Tsuchiyama1, T Yoshino, T Saito, T Furukawa, K Ito, I Fuse, Y Aizawa.   

Abstract

Acute GVHD (aGVHD) is a serious complication after allogeneic SCT (allo-SCT). However, an adequate immunological index is not yet available for assessing its severity. We analyzed the fraction of cutaneous lymphocyte antigen (CLA)+ cells in peripheral blood T and natural killer (NK) cells in 33 patients and evaluated its association with aGVHD. The CLA+ T-cell fraction often increased 3-7 days before the onset of aGVHD, and the maximum percentage of CLA+ T cells in grades II-IV aGVHD cases was significantly higher than that in grade 0 or I aGVHD (P<0.01). When the cutoff value of the maximum CLA+ T-cell percentage was set at 20%, any higher percentage was a significant risk for the development of severe aGVHD (P<0.0001). The maximum CLA+ T-cell percentage was significantly correlated with a high body temperature, low percutaneous oxygen saturation, and fibrinogen/fibrin degradation product D-dimer level. The post-allo-SCT CLA+ T cells exhibited a high ability to produce IL-2 and IFN-gamma, and may be the effectors and immunological markers for aGVHD. The CLA+ NK-cell-fraction steadily increased 2-4 weeks after allo-SCT but was not influenced by aGVHD. The CLA+ T-cell percentage may predict the development of severe aGVHD in clinical settings.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19043457     DOI: 10.1038/bmt.2008.392

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  5 in total

1.  Unique patterns of CD8+ T-cell-mediated organ damage in the Act-mOVA/OT-I model of acute graft-versus-host disease.

Authors:  Barbara Érsek; Nikolett Lupsa; Péter Pócza; Anett Tóth; Andor Horváth; Viktor Molnár; Bence Bagita; András Bencsik; Hargita Hegyesi; András Matolcsy; Edit I Buzás; Zoltán Pós
Journal:  Cell Mol Life Sci       Date:  2016-04-30       Impact factor: 9.261

2.  Xenogeneic graft-versus-host-disease in NOD-scid IL-2Rγnull mice display a T-effector memory phenotype.

Authors:  Niwa Ali; Barry Flutter; Robert Sanchez Rodriguez; Ehsan Sharif-Paghaleh; Linda D Barber; Giovanna Lombardi; Frank O Nestle
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

Review 3.  Insights into mechanisms of graft-versus-host disease through humanised mouse models.

Authors:  Amal Elhage; Chloe Sligar; Debbie Watson; Ronald Sluyter; Peter Cuthbertson
Journal:  Biosci Rep       Date:  2022-09-30       Impact factor: 3.976

4.  A Distinct Feature of T Cell Subpopulations in a Patient with CHARGE Syndrome and Omenn Syndrome.

Authors:  Toru Uchiyama; Saori Kawakami; Hiroshi Masuda; Kazue Yoshida; Hironori Niizeki; Emi Mochizuki; Kaori Edasawa; Akira Ishiguro; Masafumi Onodera
Journal:  J Clin Immunol       Date:  2020-10-06       Impact factor: 8.317

5.  A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model.

Authors:  Carina A Bäuerlein; Simone S Riedel; Jeanette Baker; Christian Brede; Ana-Laura Jordán Garrote; Martin Chopra; Miriam Ritz; Georg F Beilhack; Stephan Schulz; Robert Zeiser; Paul G Schlegel; Hermann Einsele; Robert S Negrin; Andreas Beilhack
Journal:  BMC Med       Date:  2013-05-21       Impact factor: 8.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.